Blood stasis, thrombosis and fibrinolysis.
Blood stasis is a very common occurrence associated with many of our daily activities. Prophylaxis against development of thrombosis in high-risk conditions is well established. In this issue of Hematology/Oncology Clinics of North America, international experts present new and provocative information on the basic mechanisms, diagnosis, and management of blood stasis, thrombosis, and fibrinolysis. Reviews of pertinent topics by three physicians in training also are included. I hope that the information provided will expand our understanding of this interesting subject.
Hassouna
H I
HI
D000925:Anticoagulants; D001777:Blood Coagulation; D005342:Fibrinolysis; D006487:Hemostasis; D006801:Humans; D013917:Thrombin / Q000037:antagonists & inhibitors / Q000502:physiology; D013927:Thrombosis
D000925:Anticoagulants; D013917:Thrombin